569
Participants
Start Date
August 11, 2015
Primary Completion Date
March 30, 2016
Study Completion Date
March 30, 2016
TV-46763
TV-46763 will be administered per dose and schedule specified in the arm description.
Placebo
Placebo matching to TV-46763 will be administered per schedule specified in the arm description.
Teva Investigational Site 13169, Pasadena
Teva Investigational Site 13172, San Antonio
Teva Investigational Site 13171, Salt Lake City
Teva Investigational Site 13511, St. George
Teva Investigational Site 13510, Phoenix
Teva Investigational Site 13170, Pasadena
Teva Investigational Site 13173, Anaheim
Teva Investigational Site 13174, Bakersfield
Collaborators (1)
Syneos Health
OTHER
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY